Latest News for: actuator

Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Actuate Therapeutics Inc)

Public Technologies 09 Apr 2025
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 14A. Proxy Statement Pursuant to Section 14(a) of the. Securities Exchange Act of 1934. (Amendment No. ) ... ACTUATE THERAPEUTICS, INC ... Disclaimer. Actuate Therapeutics Inc.
Edit

Olsen Actuators and Drives Expands Space Business into U.S. (ADS Group Ltd)

Public Technologies 08 Apr 2025
) Olsen Actuators and Drives has confirmed that it will open a branch office in Cape Canaveral, Florida in 2026. Image courtesy Olsen Actuators Located at the heart ...
Edit

ESI Motion Introduces Cutting-Edge SADA Actuators: Solaris

Sierra County Sentinel 08 Apr 2025
Revolutionary solutions redefine precision, and adaptability for solar/satellite and antenna applications ... .
Edit

Proxy Statement (Form DEF 14A) (Actuate Therapeutics Inc)

Public Technologies 08 Apr 2025
ACTUATE THERAPEUTICS, INC ... You are cordially invited to attend the 2025 annual meeting of stockholders (the "Annual Meeting") of Actuate Therapeutics, Inc ... You are receiving a proxy statement because you owned Actuate Therapeutics, Inc.
Edit

Commission approves Safran's acquisition of part of Collins Aerospace's actuation business, subject to conditions (European Commission - Directorate-General for Competition)

Public Technologies 04 Apr 2025
The European Commission has approved, under the EU Merger Regulation, the proposed acquisition of part of the aerospace actuation business of Collins Aerospace ('the Target') by Safran USA Inc.
Edit

Schaeffler presents complete range of Ewellix electromechanical linear actuators (Schaeffler AG)

Public Technologies 03 Apr 2025
) Ewellix EMA-100 modular electromechanical linear actuators can be adapted flexibly to any drive application Image ... Development efforts are currently focusing on highly efficient electric drive systems and electromechanical actuators.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Actuate Therapeutics Inc)

Public Technologies 02 Apr 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... 0.5 ... 2 ... ACTUATE THERAPEUTICS, INC ... C/O ACTUATE THERAPEUTICS, INC., 1751 RIVER RUN, SUITE 400 3 ... 6 ... C/O ACTUATE THERAPEUTICS, INC ... Actuate Therapeutics Inc.
Edit

Material Agreement (Form 8-K) (Actuate Therapeutics Inc)

Public Technologies 28 Mar 2025
). The text version of this document is not available ... Actuate Therapeutics Inc.
Edit

Initial Registration Statement (Form S-1) (Actuate Therapeutics Inc)

Public Technologies 28 Mar 2025
Actuate Therapeutics, Inc ... ACTUATE THERAPEUTICS, INC ... This prospectus includes our trademarks, and trade names, including but not limited to Actuate and Actuate Therapeutics, which are protected under applicable intellectual property laws.
Edit

Actuating superparamagnetic nanoparticle monolayers

PNAS 26 Mar 2025
SignificanceNanometer-thin elastic sheets containing embedded ...
  • 1
×